vs

Side-by-side financial comparison of HEALTHSTREAM INC (HSTM) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

HEALTHSTREAM INC is the larger business by last-quarter revenue ($79.7M vs $75.5M, roughly 1.1× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 7.4%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $13.0M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 4.7%).

HealthStream Inc is a leading U.S.-based provider of workforce development, compliance, and training solutions tailored for the healthcare industry. It offers cloud-based platforms covering clinical skill training, talent management, patient safety education, and regulatory adherence tools, serving over 4,000 healthcare organizations including hospitals, clinics, and long-term care facilities nationwide.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

HSTM vs PBYI — Head-to-Head

Bigger by revenue
HSTM
HSTM
1.1× larger
HSTM
$79.7M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+20.3% gap
PBYI
27.7%
7.4%
HSTM
More free cash flow
PBYI
PBYI
$1.4M more FCF
PBYI
$14.4M
$13.0M
HSTM
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
4.7%
HSTM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HSTM
HSTM
PBYI
PBYI
Revenue
$79.7M
$75.5M
Net Profit
Gross Margin
69.3%
Operating Margin
3.0%
22.7%
Net Margin
Revenue YoY
7.4%
27.7%
Net Profit YoY
EPS (diluted)
$0.09
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HSTM
HSTM
PBYI
PBYI
Q4 25
$79.7M
$75.5M
Q3 25
$76.5M
$54.5M
Q2 25
$74.4M
$52.4M
Q1 25
$73.5M
$46.0M
Q4 24
$74.2M
$59.1M
Q3 24
$73.1M
$80.5M
Q2 24
$71.6M
$47.1M
Q1 24
$72.8M
$43.8M
Net Profit
HSTM
HSTM
PBYI
PBYI
Q4 25
Q3 25
$6.1M
$8.8M
Q2 25
$5.4M
$5.9M
Q1 25
$4.3M
$3.0M
Q4 24
Q3 24
$5.7M
$20.3M
Q2 24
$4.2M
$-4.5M
Q1 24
$5.2M
$-4.8M
Gross Margin
HSTM
HSTM
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
HSTM
HSTM
PBYI
PBYI
Q4 25
3.0%
22.7%
Q3 25
9.9%
17.6%
Q2 25
7.9%
12.7%
Q1 25
6.0%
8.7%
Q4 24
6.3%
22.6%
Q3 24
8.9%
27.4%
Q2 24
6.2%
-4.6%
Q1 24
7.8%
-5.3%
Net Margin
HSTM
HSTM
PBYI
PBYI
Q4 25
Q3 25
8.0%
16.2%
Q2 25
7.2%
11.2%
Q1 25
5.9%
6.5%
Q4 24
Q3 24
7.8%
25.2%
Q2 24
5.8%
-9.6%
Q1 24
7.2%
-11.0%
EPS (diluted)
HSTM
HSTM
PBYI
PBYI
Q4 25
$0.09
$0.26
Q3 25
$0.20
$0.17
Q2 25
$0.18
$0.12
Q1 25
$0.14
$0.06
Q4 24
$0.16
$0.40
Q3 24
$0.19
$0.41
Q2 24
$0.14
$-0.09
Q1 24
$0.17
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HSTM
HSTM
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$36.2M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$354.0M
$130.3M
Total Assets
$520.4M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HSTM
HSTM
PBYI
PBYI
Q4 25
$36.2M
$97.5M
Q3 25
$53.5M
$94.4M
Q2 25
$52.1M
$96.0M
Q1 25
$77.3M
$93.2M
Q4 24
$59.5M
$101.0M
Q3 24
$57.5M
$96.7M
Q2 24
$46.1M
$96.8M
Q1 24
$52.4M
$107.2M
Total Debt
HSTM
HSTM
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
HSTM
HSTM
PBYI
PBYI
Q4 25
$354.0M
$130.3M
Q3 25
$349.2M
$115.3M
Q2 25
$350.6M
$104.7M
Q1 25
$362.8M
$97.1M
Q4 24
$359.4M
$92.1M
Q3 24
$355.5M
$71.1M
Q2 24
$349.2M
$48.5M
Q1 24
$344.9M
$51.0M
Total Assets
HSTM
HSTM
PBYI
PBYI
Q4 25
$520.4M
$216.3M
Q3 25
$499.9M
$202.9M
Q2 25
$500.1M
$194.9M
Q1 25
$524.0M
$196.2M
Q4 24
$510.8M
$213.3M
Q3 24
$502.8M
$220.7M
Q2 24
$499.6M
$205.0M
Q1 24
$511.6M
$214.1M
Debt / Equity
HSTM
HSTM
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HSTM
HSTM
PBYI
PBYI
Operating Cash FlowLast quarter
$13.2M
$14.4M
Free Cash FlowOCF − Capex
$13.0M
$14.4M
FCF MarginFCF / Revenue
16.3%
19.1%
Capex IntensityCapex / Revenue
0.3%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$59.6M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HSTM
HSTM
PBYI
PBYI
Q4 25
$13.2M
$14.4M
Q3 25
$18.0M
$9.7M
Q2 25
$5.0M
$14.1M
Q1 25
$27.1M
$3.6M
Q4 24
$11.2M
$15.6M
Q3 24
$19.1M
$11.0M
Q2 24
$6.5M
$1.0M
Q1 24
$20.9M
$11.2M
Free Cash Flow
HSTM
HSTM
PBYI
PBYI
Q4 25
$13.0M
$14.4M
Q3 25
$17.9M
$9.7M
Q2 25
$2.7M
$14.1M
Q1 25
$26.0M
$3.6M
Q4 24
$11.0M
$15.6M
Q3 24
$18.8M
$11.0M
Q2 24
$6.3M
$1.0M
Q1 24
$20.2M
FCF Margin
HSTM
HSTM
PBYI
PBYI
Q4 25
16.3%
19.1%
Q3 25
23.4%
17.7%
Q2 25
3.6%
26.8%
Q1 25
35.4%
7.7%
Q4 24
14.8%
26.4%
Q3 24
25.8%
13.7%
Q2 24
8.8%
2.1%
Q1 24
27.8%
Capex Intensity
HSTM
HSTM
PBYI
PBYI
Q4 25
0.3%
0.0%
Q3 25
0.1%
0.0%
Q2 25
3.1%
0.0%
Q1 25
1.4%
0.1%
Q4 24
0.3%
0.0%
Q3 24
0.4%
0.0%
Q2 24
0.2%
0.0%
Q1 24
1.0%
0.0%
Cash Conversion
HSTM
HSTM
PBYI
PBYI
Q4 25
Q3 25
2.96×
1.10×
Q2 25
0.93×
2.41×
Q1 25
6.25×
1.21×
Q4 24
Q3 24
3.34×
0.54×
Q2 24
1.55×
Q1 24
4.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HSTM
HSTM

Subscription Services$77.0M97%
Professional Services$2.7M3%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons